ATS 2022 Conference News Preview - 3

CONFERENCE PREVIEW EDITION | 3
PLENARY SESSION
Past President Dr. Curtis
to Address Plenary Session
J. RANDALL CURTIS, MD,
MPH, will deliver the keynote
address of the Plenary Session
at the ATS 2022 International
Conference. An
expert in critical
care, palliative care,
and pulmonary
medicine, Dr.
Curtis was the
ATS president in
ATS 2022 PLENARY
SESSION
11:30 a.m.-1 p.m. PT
Tuesday, May 17
2009-2010.
" For many years,
in many different
capacities, Randy
Curtis has been
a leader of the
ATS. He has been
an inspiration
throughout
the respiratory
community, at
no time more so
than right now. It
is our privilege to
have him as the
Keynote speaker
at our Plenary, "
said current ATS
President Lynn M.
Schnapp, MD, ATSF.
Dr. Curtis is the diUniversity.
He first went to
UW as an intern and resident,
then completed his fellowship
in pulmonary and critical care
medicine. During
his fellowship, he
also completed
the Robert
Wood Johnson
Clinical Scholars
Program and
earned a Master
of Public Health
from the UW
School of Public
Health. He is
listed in " The
Best Doctors in
America. "
Taking place
J. Randall Curtis, MD, MPH
rector of the Cambia
Palliative Care
Center of Excellence
at UW Medicine at
the University of
Washington. He is
also the A. Bruce
MontgomeryAmerican
Lung
Association endowed
chair in pulmonary
and critical
care medicine, and
UW professor of
medicine.
Dr. Curtis earned his medical
degree from Johns Hopkins
Lynn M. Schnapp, MD, ATSF
11:30 a.m.-1 p.m.
PT on Tuesday,
May 17, the
Plenary also
will include the
ratification of
the 2023 slate of
officers for the
Society, as well
as remarks from
Dr. Schnapp,
the outgoing
president, and
her successor,
Greg Downey,
MD, ATSF.
In addition,
Greg Downey, MD, ATSF
three Respiratory
Health
Awards will
be presented,
including the
Outstanding
Educator Award,
Research
Innovation &
Translation
Award, and Outstanding Clinician
Award.
BE SOCIAL WITH #ATS2022
Keep up-to-date with ATS activities before, during, and after the
International Conference. Join the conversation about #ATS2022
on any of these social media platforms.
@atscommunity
americanthoracic
@atscommunity
AmericanThoracicSociety
american-thoracic-society_2
Clinical Year in Review
Sessions Go Live for 2022
T
he ATS's essential update
across key elements of
pulmonary, critical care,
and
sleep medicine
is going
live. This is
the third year
for what has
become one
of the most
popular International Conference
events and the first time the proCLINICAL
YEAR IN REVIEW
9:30-11 a.m. PT
interstitial pneumonia, therapies
for lung cancer subtypes, and
pneumonia and pulmonary
infections.
On Monday,
Sunday-Wednesday, May 15-18
Hall E (North Building,
Exhibition Level), Moscone Center
presenters
will address
advances in
COPD, clinical
guidelines
for asthma,
gram will be presented in person.
" This Year in Review program
is focused on the most recent
state-of-the-art research and
advances across diagnostics and
therapeutics in lung disease that
is relevant to all clinicians regardless
of their workplace, " said
Jose L. Gomez, MD, MS, associate
professor of pulmonary, critical
care, and sleep medicine at Yale
University school of Medicine. " It
has very quickly become one of
the core pillars of the specialty
with essential learning for everyone
practicing pulmonary, critical
care, and sleep medicine. "
Dr. Gomez will co-chair all four
ATS Communications and Marketing
©2022 American Thoracic Society
American Thoracic Society
25 Broadway, Fourth Floor
New York, NY 10004
212-315-8600
thoracic.org
Publishing Partner
TriStar Event Media, Inc.
7285 W. 132nd St., Suite 300
Overland Park, KS 66213
tristareventmedia.com
Clinical Year in Review sessions
with Rupal J. Shah, MD, MSCE,
associate professor of pulmonary,
critical care, allergy, and sleep
medicine, University of California
San Francisco, and Juliana C.
Ferreira, MD, PhD, associate professor
of medicine, University of
São Paulo, Brazil.
Each session, from 9:30-11 a.m.
PT Sunday to Wednesday, May 1518,
will focus on different areas of
interest.
The Sunday session will include
updates on pulmonary vascular
disease, pulmonary fibrosis and
clinical developments in sleep
medicine, and the impact of
health disparities.
This Year in Review
program is focused
on the most recent
state-of-the-art
research and advances
across diagnostics
and therapeutics in
lung disease that is
relevant to all clinicians
regardless of their
workplace.
- Jose L. Gomez, MD, MS
Topics for the Tuesday session
include cystic fibrosis, sepsis,
bronchiectasis, and general
critical care.
The final Year in Review session
on Wednesday will feature the
ways COVID-19 has transformed
life for patients and clinicians,
diversity in medical education,
interventional pulmonology, and
acute respiratory distress syndrome.
https://twitter.com/atscommunity https://www.facebook.com/americanthoracic https://www.instagram.com/atscommunity/ https://www.youtube.com/americanthoracicsociety https://www.linkedin.com/company/american-thoracic-society_2/ http://thoracic.org http://tristareventmedia.com
ATS 2022 Conference News Preview

Table of Contents for the Digital Edition of ATS 2022 Conference News Preview
